SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Rating: Buy; Strong product segments of LIC driving growth

by The Outlooker Web Desk
May 28, 2023
in Business
0
Rating: Buy; Strong product segments of LIC driving growth
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

LIC (Life Insurance corporation) recorded a profit after tax (PAT) of Rs 134.3 billion in Q4FY23, displaying a remarkable four-fold increase compared to the same period last year. This substantial growth can be attributed to the transfer of Rs 73 billion from the non-par segment to the shareholders’ account, which relates to the accretion on the available solvency margin in Q4. For the full FY, LIC’s PAT surged eight-fold y-o-y, reaching Rs 364 billion. Annualised premium equivalent (APE) experienced a 12% y-o-y growth in Q4, amounting to Rs 191.3 billion.

Sequentially, APE increased by 55% compared to the last quarter. In FY23, the total APE for the year reached Rs 566.8 billion.

Also read: What does 2023 have in store for retail investors: opportunities and challenges for Indian investors

The value of new business (VNB) in Q4 of FY23 amounted to Rs 37 billion, with a significant improvement in VNB margin. The VNB margin saw a q-o-q increase of 476 bps, reaching 19.4%. Over the course of FY23, the VNB margin improved to 16.2% compared to 15.1% in FY22. These improvements in VNB margin indicate enhanced profitability and efficiency in generating new business for LIC.

The individual/group business constituted 68%/32% of APE in FY23. In the individual business, the share of PAR products remained largely stable at 91%. In total NBP, the share of PAR products was lower at 66% in FY23. Annuity/Pension and ULIPs constituted the bulk of residual, with 25% and 7%, respectively. For the non-par segment, it moderated to 70.4% v/s 73.5% in 9MFY23. We slightly raise our FY24/FY25 VNB estimates by 4%/6%. We estimate LICI to deliver a 15% CAGR in APE over FY23-25, thus enabling a 27% VNB CAGR. We maintain our Buy rating. Sales (individual NBP) in the banca channel grew 26% y-o-y to Rs 20.2 billion in FY23.

Growth in the agency channel (Individual NBP) was modest at 7% y-o-y to Rs 565 billion. However, LIC is continuously training agents to sell non-par products. Agency contributed 96% of individual NBP in FY23. The persistency ratio moderated sequentially for most cohorts other than the 25th month persistency, which grew by 46bp q-o-q.

Also read: PR Sundar puts up brave face as ‘finfluencers’ feel the heat

LICI has the levers in place to maintain the industry-leading position and ramp up growth in the highly profitable product segments (mainly Protection, Non-PAR, and Savings Annuity). However, changing gears frequires a superior and well-thought out execution. We expect LICI to deliver a 15% CAGR in APE over FY23-25, thus enabling a 27% VNB CAGR.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Nykaa: To maintain steady growth in coming years

Nykaa: To maintain steady growth in coming years

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

VOOPOO Unveils ARGUS Matrix: Curved Full Screen, Cyber-Futuristic Design, and Unmatched Performance
Tech

VOOPOO Unveils ARGUS Matrix: Curved Full Screen, Cyber-Futuristic Design, and Unmatched Performance

July 9, 2025
“Digital Compass” decodes the “Yantai Model” of China’s wine industry
Offbeat

“Digital Compass” decodes the “Yantai Model” of China’s wine industry

July 9, 2025
Is the First Lady of Sri Lanka a ‘Born Again’ devotee?
Opinion

Is the First Lady of Sri Lanka a ‘Born Again’ devotee?

July 9, 2025
Hu Yiqing, Vice President of AstraZeneca China and Head of Rare Disease Business Unit
Business

The story of multinational companies in Qingdao | AstraZeneca United Kingdom: favorable conditions, supportive policies, and an enabling environment are the confidence to increase investment in Qingdao

June 22, 2025

Connect with us

No Result
View All Result

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • September 2023
  • August 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Local
  • Movie
  • Music
  • National
  • Offbeat
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • VOOPOO Unveils ARGUS Matrix: Curved Full Screen, Cyber-Futuristic Design, and Unmatched Performance
  • “Digital Compass” decodes the “Yantai Model” of China’s wine industry
  • Is the First Lady of Sri Lanka a ‘Born Again’ devotee?

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.